Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

Objectives To assess the effects of bimagrumab on skeletal muscle mass and function in older adults with sarcopenia and mobility limitations. Design A 24‐week, randomized, double‐blind, placebo‐controlled, parallel‐arm, proof‐of‐concept study. Setting Five centers in the United States. Participan…